Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces that Vinita Bali is to join its Board as Non-Executive Director on 1 December 2014.
Roberto Quarta, Chairman of Smith & Nephew, commented:
“Vinita has an impressive track record of achievement with blue-chip global corporations in multiple geographies including India, Africa, South America, the US and UK. In particular, her strong appreciation of customer service and marketing will enable her to bring deep insight as we continue to develop innovative ways to serve our markets.”
Bali is currently a Non-Executive Director of Syngenta AG, Titan Company Ltd and CRISIL (Credit Rating Information Services of India) Ltd. She is also a Director of GAIN (Global Alliance for Improved Nutrition).
Bali was most recently Managing Director and Chief Executive Officer of Britannia Industries Ltd, a leading Indian publically listed food company (2005-2014). She started her career in India with the Tata Group, and then, in 1980, joined Cadbury India, subsequently working for Cadbury in the UK, Nigeria and South Africa. From 1994 onwards, she held a number of senior global positions in marketing and general management at The Coca-Cola Company based in the USA and South America, becoming President of the Andean Division in 1999 and Vice-President, Corporate Strategy in 2001. In 2003 she joined the consultancy Zyman Group as Managing Principal based in the USA.
Vinita Bali holds an MBA from The Jamnalal Bajaj Institute of Management Studies, University of Bombay and a bachelor’s degree in economics from the University of Delhi.
No disclosure obligations arise under paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority’s Listing Rules in respect of this appointment. Bali’s fees will be US$120,000 cash plus US$6,000 in Smith & Nephew shares per annum, in-line with current Non-Executive Directors.
- ends -
Enquiries
Investors Ingeborg Oie Smith & Nephew
+44 (0) 20 7401 7646
Media Charles Reynolds Smith & Nephew
+44 (0) 20 7401 7646
Debbie Scott / Matthew Cole FTI Strategic Consulting
+44 (0) 20 3727 1000
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 14,000 employees and a presence in more than 90 countries. Annual sales in 2013 were more than $4.3 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN). For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com
Help employers find you! Check out all the jobs and post your resume.
